BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 24460805)

  • 1. Fragmented surface ECG was a poor predictor of appropriate therapies in patients with Chagas' cardiomyopathy and ICD implantation (Fragmented ECG in CHAgas' Cardiomyopathy Study).
    Baranchuk A; Femenia F; López-Diez JC; Muratore C; Valentino M; Retyk E; Galizio N; Di Toro D; Alonso K; Hopman WM; Miranda R;
    Ann Noninvasive Electrocardiol; 2014 Jan; 19(1):43-9. PubMed ID: 24460805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QRS complex and T wave planarity for the efficacy prediction of automatic implantable defibrillators.
    Hnatkova K; Andršová I; Novotný T; Vanderberk B; Sprenkeler D; Junttila J; Reichlin T; Schlögl S; Vos MA; Friede T; Bauer A; Huikuri HV; Willems R; Schmidt G; Sticherling C; Zabel M; Malik M
    Heart; 2024 Jan; 110(3):178-187. PubMed ID: 37714697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrocardiographic characteristics associated with late gadolinium enhancement and prognostic value in patients with dilated cardiomyopathy.
    Chayanopparat P; Boonyasirinant T; Prapan N; Phoopattana S; Kaolawanich Y
    Front Cardiovasc Med; 2023; 10():1281563. PubMed ID: 37920176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fragmented QRS on far-field intracardiac electrograms as a predictor of arrhythmic events.
    Osaka Y; Ono Y; Goto K; Yabe K; Tanaka A; Miyazaki T; Suzuki A; Kurihara K; Goya M; Otomo K; Sasano T
    J Arrhythm; 2021 Oct; 37(5):1156-1161. PubMed ID: 34621414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Right Bundle Branch Block Predicts Appropriate Implantable Cardioverter Defibrillator Therapies in Patients with Non-Ischemic Dilated Cardiomyopathy and a Prophylactic Implantable Cardioverter Defibrillator.
    Jiménez-Blanco Bravo M; Alonso Salinas GL; Parra Esteban C; Toquero Ramos J; Amores Luque M; Zamorano Gómez JL; García-Izquierdo E; Álvarez-García J; Fernández Lozano I; Castro Urda V
    Diagnostics (Basel); 2024 Jun; 14(11):. PubMed ID: 38893699
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk stratifier for sudden cardiac death beyond the left ventricular ejection fraction in Chagas cardiomyopathy.
    Pedrosa RC; Paulo do Vale Madeiro J; Alberto AC; Limeira GA; de Bragança Pereira B; Matos do Nascimento E; Schlindwein FS; Ng GA
    Pacing Clin Electrophysiol; 2024 Feb; 47(2):312-320. PubMed ID: 38140904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale and study design of the MINERVA study: Multicentre Investigation of Novel Electrocardiogram Risk markers in Ventricular Arrhythmia prediction-UK multicentre collaboration.
    Ng GA; Mistry A; Newton M; Schlindwein FS; Barr C; Bates MG; Caldwell J; Das M; Farooq M; Herring N; Lambiase P; Osman F; Sohal M; Staniforth A; Tayebjee M; Tomlinson D; Whinnett Z; Yue A; Nicolson WB
    BMJ Open; 2022 Jan; 12(1):e059527. PubMed ID: 34980634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic prediction of malignant ventricular arrhythmias using neural networks in patients with an implantable cardioverter-defibrillator.
    Kolk MZH; Ruipérez-Campillo S; Alvarez-Florez L; Deb B; Bekkers EJ; Allaart CP; Van Der Lingen ACJ; Clopton P; Išgum I; Wilde AAM; Knops RE; Narayan SM; Tjong FVY
    EBioMedicine; 2024 Jan; 99():104937. PubMed ID: 38118401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of ICD indication at the time of replacement in patients with initial implant for primary prevention indication: Effect on subsequent ICD therapies.
    Dell'Era G; Degiovanni A; Occhetta E; Magnani A; Bortnik M; Francalacci G; Plebani L; Prenna E; Valsecchi S; Marino P
    Indian Pacing Electrophysiol J; 2017; 17(2):29-33. PubMed ID: 29072989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy.
    Cunha-Neto E; Dzau VJ; Allen PD; Stamatiou D; Benvenutti L; Higuchi ML; Koyama NS; Silva JS; Kalil J; Liew CC
    Am J Pathol; 2005 Aug; 167(2):305-13. PubMed ID: 16049318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indications and Effectiveness of ICD for Primary and Secondary Prevention in Patients Admitted in Ahvaz Imam Khomeini Hospital since 2017.
    Kiarsi M; Pooyanfar M; Payami B; Akiash N; Easapour Moghadam M; Seyedtabib M
    Adv Biomed Res; 2023; 12():233. PubMed ID: 38073733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological study in chagasics with syncope and conduction disorder.
    Dreicon AH; Armaganijan L; Moreira DAR; Lopes RD; Valdigem BP
    Rev Assoc Med Bras (1992); 2023; 69(12):e20230322. PubMed ID: 38055450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical characterization of myocardial damage in chronic Chagas' disease.
    Carrasco HA; Alarcon M; Olmos L; Burguera J; Burguera M; Dipaolo A; Carrasco HR
    Clin Cardiol; 1997 Oct; 20(10):865-9. PubMed ID: 9377823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the Historical Background and Clinical Implications of Electrocardiogram in the Context of Chagas Disease Research.
    Hasslocher-Moreno AM; Saraiva RM; Silva Júnior TLD; Xavier SS; Sousa AS
    Rev Soc Bras Med Trop; 2023; 56():0506. PubMed ID: 38126377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chagas disease in Virgem da Lapa, Minas Gerais, Brazil: left ventricle aneurysm and the risk of death in the 24-year interval.
    Borges-Pereira J; Coura JR; Zauza PL; Pirmez C; Xavier SS
    Mem Inst Oswaldo Cruz; 2020; 115():e200056. PubMed ID: 32556037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of a Combined Mobile-Health Electrocardiographic and Rapid Diagnostic Test Screening for Chagas-Related Cardiac Alterations.
    Spinicci M; Fumagalli C; Maurizi N; Guglielmi E; Roselli M; Gamboa H; Strohmeyer M; Poma V; Vargas R; Olivotto I; Bartoloni A
    Microorganisms; 2021 Sep; 9(9):. PubMed ID: 34576784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Undernutrition and Cachexia in Patients with Decompensated Heart Failure and Chagas Cardiomyopathy: Occurrence and Association with Hospital Outcomes.
    Tavares LCA; Lage SHG; Bocchi EA; Issa VS
    Arq Bras Cardiol; 2022 Jan; 118(1):3-11. PubMed ID: 35195201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac autonomic control mechanisms in the pathogenesis of chagas' heart disease.
    Dávila DF; Donis JH; Arata de Bellabarba G; Villarroel V; Sanchez F; Berrueta L; Salmen S; Das Neves B
    Interdiscip Perspect Infect Dis; 2012; 2012():980739. PubMed ID: 23091486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LAMP2 shines a light on cardiomyopathy in an athlete.
    Martin S; Ingles J; Hunyor I; Bagnall RD; Puranik R; Semsarian C
    HeartRhythm Case Rep; 2017 Mar; 3(3):172-176. PubMed ID: 28491796
    [No Abstract]   [Full Text] [Related]  

  • 20. [First appropriate implantable defibrillator shocks in patients with Chagasic heart disease].
    García-Chamorro LG; Zaidel EJ; Gheco L; Oliva MA; de-la-Vega A; Orosco A; Armentano J; Sosa-Liprandi Á
    Arch Cardiol Mex; 2022 Jul; 92(3):342-348. PubMed ID: 34619749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.